{"id":"amphora","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Amphora","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:28:45.144386+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:28:51.573482+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Amphora","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:28:52.031233+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"a33c1124-16ed-6e67-e053-2a95a90ac3e4","title":"AMPHORA AROMATICS HAND SANITIZER (HAND SANITIZER) GEL [QINGDAO AMPHORA AROMATICS CO.,LTD]"},"ecosystem":[],"_scrapedAt":"2026-03-28T00:44:33.009Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:28:54.233639+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT01306331","phase":"PHASE3","title":"Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel","status":"COMPLETED","sponsor":"Evofem Inc.","startDate":"2011-04","conditions":"Contraception","enrollment":3389},{"nctId":"NCT03243305","phase":"PHASE3","title":"AMP002 Phase III Contraceptive Study","status":"COMPLETED","sponsor":"Evofem Inc.","startDate":"2017-07-24","conditions":"Contraception","enrollment":1384},{"nctId":"NCT03107377","phase":"PHASE2, PHASE3","title":"Phase 2B/3 Double-blinded Placebo-controlled","status":"COMPLETED","sponsor":"Evofem Inc.","startDate":"2017-11-03","conditions":"Chlamydia Trachomatis Infection","enrollment":860},{"nctId":"NCT02398578","phase":"PHASE1, PHASE2","title":"Cystoscopic Ablation Via RF Energy Clinical Trial","status":"TERMINATED","sponsor":"Amphora Medical, Inc.","startDate":"2015-02","conditions":"Overactive Bladder","enrollment":63},{"nctId":"NCT00850837","phase":"PHASE1","title":"Safety of Acidform Lubricant in HIV-Uninfected Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-02","conditions":"HIV Infections","enrollment":35}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":282,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Amphora","genericName":"Amphora","companyName":"Evofem Inc.","companyId":"evofem-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:28:54.233639+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}